title: Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder.
abstract: Legislative changes that came into effect in the UK in April 2012 gave nurse independent prescribers (NIPs) the power to prescribe schedule 2-5 controlled drugs. Therefore, suitably qualified UK nurses can now independently prescribe any drug for any medical condition within their clinical competence. The potential benefits of independent nurse prescribing include improved access to medications and more efficient use of skills within the National Health Service workforce. This review explores the published literature (to July 2013) to investigate whether the predicted benefits of NIPs in mental health settings can be supported by empirical evidence, with a specific focus on nurse-led management of patients with attention-deficit/hyperactivity disorder (ADHD). The most common pharmacological treatments for ADHD are controlled drugs. Therefore, the 2012 legislative changes allow nurse-led ADHD services to offer holistic packages of care for patients. Evidence suggests that independent prescribing by UK nurses is safe, clinically appropriate and associated with high levels of patient satisfaction. The quality of the nurse-patient relationship and nurses' ability to provide flexible follow-up services suggests that nurse-led ADHD services are well positioned to enhance the outcomes for patients and their parents/carers. However, the empirical evidence available to support the value of NIPs in mental health settings is limited. There is a need for additional high-quality data to verify scientifically the value of nurse-delivered ADHD care. This evidence will be invaluable in supporting the growth of nurse-led ADHD services and for those who support greater remuneration for the expanded role of NIPs.
authors.affiliation: Shire, Unity Place, Hampshire International Business Park, Basingstoke, RG24 8EP, UK, lmangle@shire.com.
authors.forename: Lisa
authors.initials: L
authors.lastname: Mangle
authors.forename: Paula
authors.initials: P
authors.lastname: Phillips
authors.forename: Mark
authors.initials: M
authors.lastname: Pitts
authors.forename: Cathy
authors.initials: C
authors.lastname: Laver-Bradbury
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing*; D002983:Clinical Competence; D003362:Cost-Benefit Analysis; D011307:Drug Prescriptions / Q000451:nursing* / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D024802:Nurse's Role; D057184:Practice Patterns, Nurses' / Q000191:economics / Q000592:standards*; D006113:United Kingdom
references.citation: J Psychiatr Ment Health Nurs. 2012 Aug;19(6):475-81
references.pmid: 22070189
references.citation: Pediatr Nurs. 2006 Jan-Feb;32(1):18-24
references.pmid: 16572535
references.citation: Acad Pediatr. 2012 Mar-Apr;12(2):110-6
references.pmid: 22326727
references.citation: J Clin Psychiatry. 2011 Jul;72(7):1008-14
references.pmid: 21824459
references.citation: Child Adolesc Psychiatry Ment Health. 2008 Oct 28;2(1):31
references.pmid: 18957105
references.citation: BMJ Open. 2012 Nov 23;2(6):
references.pmid: 23180453
references.citation: Curr Pharm Des. 2010;16(22):2416-23
references.pmid: 20513228
references.citation: Eur J Clin Pharmacol. 2013 Apr;69(4):761-70
references.pmid: 23052418
references.citation: Postgrad Med. 2010 Jan;122(1):184-91
references.pmid: 20107302
references.citation: J Psychopharmacol. 2007 Jan;21(1):10-41
references.pmid: 17092962
references.citation: J Adv Nurs. 2013 Jul;69(7):1478-88
references.pmid: 22989189
references.citation: J Psychiatr Ment Health Nurs. 2011 Apr;18(3):189-97
references.pmid: 21395910
references.citation: J Psychiatr Ment Health Nurs. 2010 Nov;17(9):804-12
references.pmid: 21040226
references.citation: BMC Health Serv Res. 2009 Dec 21;9:242
references.pmid: 20025770
references.citation: J Psychiatr Ment Health Nurs. 2009 Apr;16(3):257-62
references.pmid: 19291154
references.citation: Fam Pract. 2012 Apr;29(2):223-7
references.pmid: 21965550
references.citation: Respir Med. 2011 Sep;105(9):1308-15
references.pmid: 21511454
references.citation: J Adv Nurs. 2013 Mar;69(3):535-45
references.pmid: 22551089
references.citation: Nurs Times. 2010 Aug 31-Sep 6;106(34):10-2
references.pmid: 20882824
references.citation: J Health Serv Res Policy. 2012 Jul;17(3):149-56
references.pmid: 22734082
references.citation: J Am Acad Nurse Pract. 2010 Nov;22(11):593-601
references.pmid: 21054633
references.citation: BMC Pediatr. 2012 Jun 19;12:78
references.pmid: 22712630
references.citation: J Psychiatr Ment Health Nurs. 2014 Feb;21(1):1-10
references.pmid: 23413877
references.citation: Neurotherapeutics. 2012 Jul;9(3):490-9
references.pmid: 22976615
references.citation: Int J Geriatr Psychiatry. 2008 Jan;23(1):27-33
references.pmid: 17487937
references.citation: J Psychiatr Ment Health Nurs. 2011 May;18(4):281-7
references.pmid: 21418427
references.citation: Am J Psychiatry. 2007 Jun;164(6):942-8
references.pmid: 17541055
references.citation: BMC Fam Pract. 2012 Apr 05;13:30
references.pmid: 22480341
references.citation: Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001271
references.pmid: 15846614
references.citation: J Psychiatr Ment Health Nurs. 2012 Dec;19(10):916-32
references.pmid: 22295995
references.citation: Arch Dis Child. 2010 Jul;95(7):513-7
references.pmid: 20530525
references.citation: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011
references.pmid: 18425859
references.citation: J Adv Nurs. 2011 Jun;67(6):1341-8
references.pmid: 21375572
references.citation: Int J Clin Pharm. 2013 Apr;35(2):268-74
references.pmid: 23277419
references.citation: J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1170-2
references.pmid: 16024902